Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;170(Suppl 6):482-486.
doi: 10.1007/s00112-022-01530-8. Epub 2022 Jun 30.

[2/m-Fever 39.5 °C for 5 days]

[Article in German]
Prasad T Oommen  1 , Anton Hospach  2
Affiliations

[2/m-Fever 39.5 °C for 5 days]

[Article in German]
Prasad T Oommen et al. Monatsschr Kinderheilkd. 2022.
No abstract available

PubMed Disclaimer

References

    1. McCrindle BW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi: 10.1161/CIR.0000000000000484. - DOI - PubMed
    1. Ozen S, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–941. doi: 10.1136/ard.2005.046300. - DOI - PMC - PubMed
    1. Kobayashi T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613–1620. doi: 10.1016/S0140-6736(11)61930-2. - DOI - PubMed
    1. AWMF-Leitlinie (Register nummer 185-003). https://www.awmf.org/ploads/tx_szleitlinien/185-003l_S2k_Kawasaki-Syndro.... Zugegriffen: 14.04.2022
    1. Kone-Paut I, et al. Phase II open label study of Anakinra in intravenous immunoglobulin-resistant Kawasaki disease. Arthritis Rheumatol. 2021;73(1):151–161. doi: 10.1002/art.41481. - DOI - PubMed

LinkOut - more resources